13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

Page 8 of 9 – SEC Filing


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is
true, complete and correct.

Dated as of August 31, 2017

SCOPIA CAPITAL MANAGEMENT LP
By: Scopia Management, Inc., its general partner
By:

/s/ Matthew Sirovich

Name: Matthew Sirovich
Title: Managing Director
SCOPIA MANAGEMENT, INC.
By:

/s/ Matthew Sirovich

Name: Matthew Sirovich
Title: Managing Director
By:

/s/ Matthew Sirovich

By:

/s/ Jeremy Mindich

Follow Acorda Therapeutics Inc. (NASDAQ:ACOR)